FIRST EXPERIENCE WITH A NEW ECHOGRAPHIC CONTRAST AGENT

被引:16
作者
CENNAMO, G [1 ]
ROSA, N [1 ]
VALLONE, GF [1 ]
SMALTINO, F [1 ]
机构
[1] UNIV NAPLES FEDERICO II,IST SCI RADIOL,I-80131 NAPLES,ITALY
关键词
D O I
10.1136/bjo.78.11.823
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The intravenous injection of an ultrasound contrast agent can enhance signals from blood flow. Broad toxicological and pharmaceutical studies in animals confirmed the safety and efficacy of an ultrasound contrast agent made of microparticles of galactose with stabilised microbubbles in watery suspension (SH U 508 A). In this paper 10 patients with different malignant orbital and ocular tumours have been evaluated with an echo colour Doppler machine before and after the injection of SH U 508 A. An enhancement of the Doppler signals in the lesions in different degrees has been detected. This echographic contrast agent seems to be very important not only in the evaluation of vascular lesions, but also in evaluating the effectiveness of radio-therapy in malignant tumours and could spread the echographic indications in several other ophthalmic fields.
引用
收藏
页码:823 / 826
页数:4
相关论文
共 17 条
  • [1] ATTA HR, 1988, ARCH OPHTHALMOL-CHIC, V106, P1234
  • [2] Burns P N, 1993, Radiol Med, V85, P3
  • [3] CENNAMO G, 1994, IN PRESS DOC OPHTHAL
  • [4] FRAZIERBYRNE S, 1983, OPHTHALMOLOGY, V90, P1071
  • [5] FRITZSCH T, 1990, INVEST RADIOL, V25, P160
  • [6] GRAMIAK R, 1968, INVEST RADIOL, V3, P356
  • [7] GUTHOFF R, 1992, ACTA OPHTHALMOL S, V204, P59
  • [8] JAIN R, 1992, ACTA OPHTHALMOL S, V204, P46
  • [9] NANDA NC, 1990, ADV ECHO CONTRAST, V1, P3
  • [10] CONTRAST AGENTS IN DIAGNOSTIC ULTRASOUND
    OPHIR, J
    PARKER, KJ
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 1989, 15 (04) : 319 - 333